Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
350 participants
INTERVENTIONAL
2006-09-30
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
NCT02556801
SUBLIVAC FIX Phleum Pratense DT/DRF
NCT01682070
SUBLIVAC FIX Mite Mixture Dose Tolerability Study
NCT02345278
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Number of centres: approximately 50.
Study period planned: Q2-2006 until Q3-2008 Analysis after one exposed season (2007); based on the outcome the study will be stopped or continued for another season.
Subject selection criteria: Seasonal rhinitis and/or rhinoconjunctivitis with or without mild asthma (FEV1 \> 70%) related to grass pollen, age 12 years or older.
Dosage schedule: Start with two drops daily of SUBLIVAC® and increase by two drops daily, until the maintenance dose of 10 drops SUBLIVAC® GrassesSUBLIVAC® Grasses is reached.
Route of administration: Sublingual application (drops are to be held underneath the tongue for 2-3 minutes and then will be swallowed).
Duration of treatment: 6 to 12 months blinded per subject . Efficacy parameters
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
SUBLIVAC® Grasses treatment
SUBLIVAC® Grasses/Placebo treatment
SUBLIVAC® Grasses/Placebo treatment
SUBLIVAC® Grasses treatment
SUBLIVAC® Grasses treatment
2
Placebo treatment
SUBLIVAC® Grasses/Placebo treatment
SUBLIVAC® Grasses/Placebo treatment
Placebo treatment
Placebo treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SUBLIVAC® Grasses/Placebo treatment
SUBLIVAC® Grasses/Placebo treatment
SUBLIVAC® Grasses treatment
SUBLIVAC® Grasses treatment
Placebo treatment
Placebo treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A positive skin prick test (\>3 mm) for early flowering treesgrasses and specific serum IgE-test(\>1 U/ml) for grass pollen (Lolium perenne, Phleum pratense and Poa pratensis).
Exclusion Criteria
* Allergy to any of the excipients
* Symptoms related to concomitant sensitisation to perennial allergens of pets
* Chronic asthma or emphysema, particularly with a FEV1 \< 70 % of predicted value or use of inhalation corticosteroids outside grass and tree pollen season for more than two episodes and/or longer than fourteen days
* Use of symptomatic medication for more than three episodes and/or longer than three days outside the tree- or grass pollen season
* Serious immuno-pathological diseases or malignancies (including auto-immune diseases, tuberculosis, HIV)
* Inflammation and infection of the target organ
* Severe atopic dermatitis requiring systemic immuno-suppressive medication
* Allergen specific immuno-therapy treatment within the last 5 years for a period longer than three months
* History of life threatening anaphylactic events, including anaphylactic food allergy, insect venom anaphylaxis, exercise or drug induced anaphylaxis
* A positive pregnancy test, lactation or inadequate contraceptive measures Alcohol- or drug abuse
* Lack of co-operation or severe psychological disorders
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HAL Allergy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HAL Allergy BV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
R Peter, Prof.Dr.med
Role: PRINCIPAL_INVESTIGATOR
Zentrum für Klinische Forschung, Helholzstrasse 8/1, 89081 Ulm, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. P. van Durme
Antwerp, , Belgium
Centrum Gespecialiseerde Geneeskunde Genk
Genk, , Belgium
UZ Gent, Dienst NKO, 1P1
Ghent, , Belgium
UZ Gasthuisberg, Afd. Allergie/Immunologie
Leuven, , Belgium
UZ Gasthuisberg, Dienst Kindergeneeskunde
Leuven, , Belgium
UZ Gasthuisberg, lokatie St. Rafaël
Leuven, , Belgium
Kinderallergie-Astma kinderz.
Mechelen, , Belgium
Allergologie Aachen
Aachen, , Germany
Charité - Universitätsmedizin Berlin
Berlin, , Germany
Studienzentrum Berlin
Berlin, , Germany
Allergologie Braunschweig
Braunschweig, , Germany
Priv.-Doz. Hals-Nasen-Ohrenheilkunde plastische Operationen Allergologie
Darmstadt, , Germany
Allergologie Dorsten
Dorsten, , Germany
Hals, Nasen- u. Ohrenheilkunde Dortmund
Dortmund, , Germany
Hals, Nasen- u. Ohrenheilkunde Duisburg
Duisburg, , Germany
Medi-Center Düren
Düren, , Germany
Hals, Nasen- u. Ohrenheilkunde Düsseldorf
Düsseldorf, , Germany
Heinrich-Heine-Universität Düsseldorf, Hautklinik
Düsseldorf, , Germany
Universität Erlangen, Poliklinik für Kinder und Jugendliche
Erlangen, , Germany
Gemeinschaftspraxis Dr. M. Feldmann und Dr. N. Karadiakos
Essen, , Germany
Hals, Nasen- u. Ohrenheilkunde Essen
Essen, , Germany
Hals, Nasen- u. Ohrenheilkunde Essen
Essen, , Germany
Allergologie Gifhorn
Gifhorn-Winkel, , Germany
Drobnitzky Franz-Josef Dr.med. Kinderarzt-Allergologie und Frank-Peter Dr.med. Kinderarzt-Neonatologie Gemeinschaftspraxis
Gütersloh, , Germany
Klinik für Pneumologie, Intensiv- und Schlafmedizin Klinikum
Hanover, , Germany
Med.Hochschule Hannover, Kinderklinik
Hanover, , Germany
Allergologie Jülich
Jülich, , Germany
Allergologie Kassel
Kassel, , Germany
HNO - Krefeld
Krefeld, , Germany
Hals, Nasen- u. Ohrenheilkunde Lüdenscheid
Lüdenscheid, , Germany
Allgemeinmedizin Stockach, Baden
Stockach, , Germany
Zentrum für Klinische Forschung, Helmholtzstrasse 8/1, 89081 Ulm, Germany
Ulm, , Germany
Gemeinschaftspraxis für HNO Heilkunde, Allergologie und plastische Chirurgie
Wiesbaden, , Germany
Hals, Nasen- u. Ohrenheilkunde Willich
Willich, , Germany
Gemeinschaftspraxis für Hals-Nasen-Ohrenheilkunde
Wuppertal, , Germany
Meander Medisch Centrum, lokatie Baarn, Afdeling KNO
Amersfoort, , Netherlands
Allergologen Maatschap Arnhem
Arnhem, , Netherlands
Wilhelmina Ziekenhuis Assen, Afdeling KNO
Assen, , Netherlands
Vlietland Ziekenhuis, lokatie Schiedam, KNO
Schiedam, , Netherlands
Medical University of Bialystok, Department of Pediatrics and Allergology
Bialystok, , Poland
Medical University of Gdansk, Department of Allergology
Gdansk, , Poland
FARMA-MED. Sp. z o. o.
Inowrocław, , Poland
Jagiellonian University Medical College, Department of Allergy and Immunology
Krakow, , Poland
Jagiellonian University Medical College, Department of Allergology and Dermatology
Krakow, , Poland
Klinika Pneumonologii i Alergologii Uniwersytet Medyczny w Lodzi
Lodz, , Poland
NZOZ Centrum Alergologii
Lodz, , Poland
Medical University of Lodz, Department of Allergology and Pulmonology
Lodz, , Poland
Medical University of Lodz, Department of Clinical Immunology and Allergy
Lodz, , Poland
Medical University of Lodz, Department of Pediatrics and Allergology
Lodz, , Poland
Medical University of Lublin, Department of Allergology and Immunotherapy
Lublin, , Poland
Klinika Pneumonologii Onkologii i Alergologii SPSK Nr 4
Lublin, , Poland
Oddzial Dzieciecy SPZOZ
Pabianice, , Poland
Institute of Allergy and Lung Disease Rabka, Department of Allergology and Pneumonology
Rabka-Zdrój, , Poland
Specjalistyczny Zespól Diagnostyczno-Konsultacyjny Problemów Alergii Emil Florkiewicz
Sieradz, , Poland
Gabinet Lekarski Bozena Kubicka-Kozik Poradnia Alergologiczna
Tomaszów Mazowiecki, , Poland
Specjalistyczny Niepubliczny Zaklad Leczenia Alergii i Diagnostyki Alergologicznej IRMED 2
Warsaw, , Poland
Military Institute of the Health Services, Department of Infection Disease and Allergology
Warsaw, , Poland
Military Institute of the Health Services, Department of Internal Disease Pulmonology and Allergology
Warsaw, , Poland
Medical University of Wroclaw, Department of Internal Disease and Allergology
Wroclaw, , Poland
Medical University of Silesia, Department of Internal Disease, Allergology and Clinical Immunology
Zabrze, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EudraCTnr: 2005-005175-16
Identifier Type: -
Identifier Source: secondary_id
SG/0021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.